Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A22061 | 24845607 | J Hepatol | Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice. | 2014 | Details |
| A22062 | 24845341 | Liver Int | Reduced hepatic lipid content in Pten-haplodeficient mice because of enhanced AKT2/PKBβ activation in skeletal muscle. | 2014 | Details |
| A22063 | 24845056 | Hepatology | Dual role of B7 costimulation in obesity-related nonalcoholic steatohepatitis and metabolic dysregulation. | 2014 | Details |
| A22064 | 24844310 | Eat Weight Disord | Which metabolic syndrome criteria best predict non-alcoholic fatty liver disease in children? | 2014 | Details |
| A22065 | 24843757 | J Diabetes Investig | Prevalences of diabetic retinopathy and nephropathy are lower in Korean type 2 diabetic patients with non-alcoholic fatty liver disease. | 2013 | Details |
| A22066 | 24843721 | J Diabetes Investig | Modification of a simple clinical scoring system as a diagnostic screening tool for non-alcoholic steatohepatitis in Japanese patients with non-alcoholic fatty liver disease. | 2013 | Details |
| A22067 | 24843703 | J Diabetes Investig | Role of thiazolidinediones, insulin sensitizers, in non-alcoholic fatty liver disease. | 2013 | Details |
| A22068 | 24843689 | J Diabetes Investig | Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: Role of adipokines. | 2013 | Details |
| A22069 | 24842304 | J Hepatol | Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia. | 2014 | Details |
| A22070 | 24841999 | Food Funct | Persimmon tannin accounts for hypolipidemic effects of persimmon through activating of AMPK and suppressing NF-κB activation and inflammatory responses in high-fat diet rats. | 2014 | Details |
| A22071 | 24841950 | Obes Surg | The diagnostic accuracy of transient elastography for the diagnosis of liver fibrosis in bariatric surgery candidates with suspected NAFLD. | 2014 | Details |
| A22072 | 24840769 | Pediatr Radiol | Quantitative MRI for hepatic fat fraction and T2* measurement in pediatric patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A22073 | 24838722 | BMJ Open | Clinical outcomes and resource utilisation in Medicare patients with chronic liver disease: a historical cohort study. | 2014 | Details |
| A22074 | 24837835 | Int J Mol Sci | Role of mitochondria in nonalcoholic fatty liver disease. | 2014 | Details |
| A22075 | 24837195 | Clin Exp Pharmacol Physiol | Non-alcoholic fatty liver disease (NAFLD) fibrosis score predicts 6.6-year overall mortality of Chinese patients with NAFLD. | 2014 | Details |
| A22076 | 24836834 | Transplant Proc | Nonalcoholic Fatty liver disease in renal transplant recipients proven by transient elastography. | 2014 | Details |
| A22077 | 24834836 | Biol Rev Camb Philos Soc | Intracellular role of exchangeable apolipoproteins in energy homeostasis, obesity and non-alcoholic fatty liver disease. | 2014 | Details |
| A22078 | 24834820 | Environ Res | Secondhand tobacco exposure is associated with nonalcoholic fatty liver disease in children. | 2014 | Details |
| A22079 | 24833862 | World J Gastroenterol | Liver transplantation for nonalcoholic fatty liver disease: new challenges and new opportunities. | 2014 | Details |
| A22080 | 24831885 | Genet Test Mol Biomarkers | Genetic variants in the PNPLA3 gene are associated with nonalcoholic steatohepatitis. | 2014 | Details |
| A22081 | 24830635 | Horm Metab Res | Additive effects of nicotine and high-fat diet on hepatocellular apoptosis in mice: involvement of caspase 2 and inducible nitric oxide synthase-mediated intrinsic pathway signaling. | 2014 | Details |
| A22082 | 24830603 | Exp Mol Pathol | Lipidomic analysis of the liver from high-fat diet induced obese mice identifies changes in multiple lipid classes. | 2014 | Details |
| A22083 | 24830559 | Int J Mol Sci | Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation. | 2014 | Details |
| A22084 | 24829925 | J Diabetes Res | Ketosis onset type 2 diabetes had better islet β-cell function and more serious insulin resistance. | 2014 | Details |
| A22085 | 24829735 | Int J Prev Med | Hepatic Artery and Portal Vein Doppler Indexes in Non-alcoholic Fatty Liver Disease Before and After Treatment to Prevent Unnecessary Health Care Costs. | 2014 | Details |
| A22086 | 24829701 | Middle East J Dig Dis | Oral Nitrate Reductase Activity Is Not Associated with Development of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Pilot Study. | 2014 | Details |
| A22087 | 24829700 | Middle East J Dig Dis | Causes of Persistently Elevated Alanine Aminotransferase Levels in Patients who Presented to Two Referral Hospitals in Mashhad, Iran during 2011. | 2014 | Details |
| A22088 | 24829682 | Middle East J Dig Dis | Probiotics and Nonalcoholic Fatty liver Disease. | 2013 | Details |
| A22089 | 24829591 | Hepat Mon | Nonalcoholic Fatty liver disease/non-alcoholic steatohepatitis in childhood: endocrine-metabolic "mal-programming". | 2014 | Details |
| A22090 | 24829577 | Int J Endocrinol | Visceral adiposity index: an indicator of adipose tissue dysfunction. | 2014 | Details |
| A22091 | 24828988 | Eur J Clin Invest | Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance. | 2014 | Details |
| A22092 | 24827819 | Mol Nutr Food Res | Effect of methionine-deficient and methionine-supplemented diets on the hepatic one-carbon and lipid metabolism in mice. | 2014 | Details |
| A22093 | 24827629 | Gut Liver | Gallstone disease does not predict liver histology in nonalcoholic fatty liver disease. | 2014 | Details |
| A22094 | 24826079 | Hepat Med | Lifestyle interventions for the treatment of non-alcoholic fatty liver disease. | 2013 | Details |
| A22096 | 24824123 | Zhonghua Gan Zang Bing Za Zhi | [Relationship of non-alcoholic steatohepatitis with arterial endothelial function and atherosclerosis]. | 2014 | Details |
| A22097 | 24824122 | Zhonghua Gan Zang Bing Za Zhi | [Prospective cohort study of the predictive value of hemoglobin levels for non-alcoholic fatty liver disease]. | 2014 | Details |
| A22098 | 24824077 | J Hepatobiliary Pancreat Sci | Paradoxical impact of the remnant pancreatic volume and infectious complications on the development of nonalcoholic fatty liver disease after pancreaticoduodenectomy. | 2014 | Details |
| A22099 | 24823873 | Diabetes Metab Res Rev | Benefits of exenatide on obesity and non-alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetes. | 2014 | Details |
| A22101 | 24821109 | Biochem Pharmacol | Cyanidin-3-O-β-glucoside protects primary mouse hepatocytes against high glucose-induced apoptosis by modulating mitochondrial dysfunction and the PI3K/Akt pathway. | 2014 | Details |
| A22102 | 24819989 | Steroids | Bile acids are nutrient signaling hormones. | 2014 | Details |
| A22103 | 24819229 | Metab Syndr Relat Disord | Interrelationships of serum androgens, omental adipose tissue metabolism, and nonalcoholic fatty liver disease in obese premenopausal women. | 2014 | Details |
| A22104 | 24818764 | Gastroenterology | No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial. | 2014 | Details |
| A22105 | 24816759 | Horm Metab Res | Effect of fructose and 3,5-diiodothyronine (3,5-T(2)) on lipid accumulation and insulin signalling in non-alcoholic fatty liver disease (NAFLD)-like rat primary hepatocytes. | 2014 | Details |
| A22106 | 24816727 | J Physiol Biochem | Bile acid supplementation improves established liver steatosis in obese mice independently of glucagon-like peptide-1 secretion. | 2014 | Details |
| A22107 | 24816278 | PLoS One | Lactoferrin dampens high-fructose corn syrup-induced hepatic manifestations of the metabolic syndrome in a murine model. | 2014 | Details |
| A22108 | 24815820 | Food Chem Toxicol | Drug metabolism enzymes in a steatotic model of rat treated with a high fat diet and a low dose of streptozotocin. | 2014 | Details |
| A22109 | 24815326 | Clin Gastroenterol Hepatol | The fatty acid-bile acid conjugate Aramchol reduces liver fat content in patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A22110 | 24815080 | Dig Liver Dis | Statin therapy is associated with a reduced risk of non-alcoholic fatty liver in overweight individuals. | 2014 | Details |
| A22111 | 24814684 | Metabolism | De novo lipogenesis in health and disease. | 2014 | Details |
| A22113 | 24812009 | Toxicol Sci | Human receptor activation by aroclor 1260, a polychlorinated biphenyl mixture. | 2014 | Details |
| A22114 | 24811405 | Appl Microbiol Biotechnol | Preventing non-alcoholic fatty liver disease through Lactobacillus johnsonii BS15 by attenuating inflammation and mitochondrial injury and improving gut environment in obese mice. | 2014 | Details |
| A22115 | 24806753 | Hepatology | FAM3A activates PI3K p110α/Akt signaling to ameliorate hepatic gluconeogenesis and lipogenesis. | 2014 | Details |
| A22116 | 24805248 | Curr Vasc Pharmacol | Effect of rosuvastatin on non-alcoholic steatohepatitis in patients with metabolic syndrome and hypercholesterolaemia: a preliminary report. | 2014 | Details |
| A22117 | 24803983 | Oxid Med Cell Longev | BL153 partially prevents high-fat diet induced liver damage probably via inhibition of lipid accumulation, inflammation, and oxidative stress. | 2014 | Details |
| A22118 | 24803810 | World J Gastroenterol | NAFLD prevalence differs among hispanic subgroups: the Multi-Ethnic Study of Atherosclerosis. | 2014 | Details |
| A22119 | 24802098 | Mamm Genome | Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse. | 2014 | Details |
| A22120 | 24801211 | PLoS One | Prediction of metabolic syndrome by non-alcoholic fatty liver disease in northern urban Han Chinese population: a prospective cohort study. | 2014 | Details |
| A22121 | 24799990 | World J Hepatol | Pediatric non-alcoholic fatty liver disease: New insights and future directions. | 2014 | Details |
| A22122 | 24799988 | World J Hepatol | Insulin sensitizers for the treatment of non-alcoholic fatty liver disease. | 2014 | Details |
| A22123 | 24799987 | World J Hepatol | Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease. | 2014 | Details |
| A22124 | 24799985 | World J Hepatol | Lipid lowering effects of iodothyronines: In vivo and in vitro studies on rat liver. | 2014 | Details |
| A22125 | 24799031 | Clin Imaging | Is diffusion-weighted imaging a significant indicator of the development of vascularization in hypovascular hepatocellular lesions? | 2014 | Details |
| A22126 | 24798049 | Liver Int | The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A22127 | 24797980 | Adv Med Sci | Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease. | 2014 | Details |
| A22128 | 24797780 | Cas Lek Cesk | [Relation of risk factors between metabolic syndrome and nonalcoholic fatty liver disease in children and adolescents]. | 2014 | Details |
| A22130 | 24797416 | Sci Rep | Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota. | 2014 | Details |
| A22131 | 24797163 | Sci Rep | Lipid modulatory activities of Cichorium glandulosum Boiss et Huet are mediated by multiple components within hepatocytes. | 2014 | Details |
| A22132 | 24796231 | Hepatol Res | Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J). | 2014 | Details |
| A22133 | 24796105 | Nihon Rinsho | [Liver diseases]. | 2014 | Details |
| A22134 | 24795800 | Toxicol Res | Hepatoprotective effect of aged black garlic extract in rodents. | 2014 | Details |
| A22135 | 24795720 | Front Immunol | Role of innate immune response in non-alcoholic Fatty liver disease: metabolic complications and therapeutic tools. | 2014 | Details |
| A22136 | 24795254 | Lancet Diabetes Endocrinol | Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial. | 2014 | Details |
| A22138 | 24795036 | Dig Dis Sci | Caspase 3 inactivation protects against hepatic cell death and ameliorates fibrogenesis in a diet-induced NASH model. | 2014 | Details |
| A22139 | 24794207 | J Am Soc Hypertens | Adiponectin is better predictor of subclinical atherosclerosis than liver function tests in patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A22140 | 24793441 | J Clin Lipidol | An assessment by the Statin Liver Safety Task Force: 2014 update. | 2014 | Details |
| A22141 | 24793377 | Food Chem Toxicol | Comparative study of bisphenol A and its analogue bisphenol S on human hepatic cells: a focus on their potential involvement in nonalcoholic fatty liver disease. | 2014 | Details |
| A22142 | 24793347 | J Clin Lipidol | Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: the role of interdisciplinary therapy. | 2014 | Details |
| A22144 | 24791845 | Med Ultrason | Ultrasound screening for hepatocellular carcinoma in patients with advanced liver fibrosis. An overview. | 2014 | Details |
| A22145 | 24791843 | Med Ultrason | Comparison between the M and XL probes for liver fibrosis assessment by transient elastography. | 2014 | Details |
| A22146 | 24789994 | Am J Physiol Regul Integr Comp Physiol | Oxidative stress and altered lipid homeostasis in the programming of offspring fatty liver by maternal obesity. | 2014 | Details |
| A22147 | 24788803 | Drug Saf | Benefit-risk assessment of rosuvastatin in the treatment of atherosclerosis and related diseases. | 2014 | Details |
| A22148 | 24788149 | PLoS One | Lipotoxic effect of p21 on free fatty acid-induced steatosis in L02 cells. | 2014 | Details |
| A22149 | 24786317 | Exp Cell Res | Human mesenchymal stem cells towards non-alcoholic steatohepatitis in an immunodeficient mouse model. | 2014 | Details |
| A22150 | 24786290 | Int J Mol Sci | Current status in the therapy of liver diseases. | 2014 | Details |
| A22151 | 24786095 | Int J Mol Sci | Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH). | 2014 | Details |
| A22152 | 24785962 | Curr Opin Lipidol | Fatty acid sources and their fluxes as they contribute to plasma triglyceride concentrations and fatty liver in humans. | 2014 | Details |
| A22153 | 24785259 | Endocr J | Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits. | 2014 | Details |
| A22154 | 24784707 | Mol Cell Endocrinol | Resolvin D1 reduces ER stress-induced apoptosis and triglyceride accumulation through JNK pathway in HepG2 cells. | 2014 | Details |
| A22155 | 24783906 | Med Arch | Anthropometric and biochemical characteristics of patients with nonalcoholic fatty liver diagnosed by non-invasive diagnostic methods. | 2014 | Details |
| A22156 | 24782632 | World J Gastroenterol | Proteomic analysis of liver mitochondria from rats with nonalcoholic steatohepatitis. | 2014 | Details |
| A22157 | 24782622 | World J Gastroenterol | Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients. | 2014 | Details |
| A22158 | 24782263 | Semin Liver Dis | Hepatic pathology among patients without known liver disease undergoing bariatric surgery: observations and a perspective from the longitudinal assessment of bariatric surgery (LABS) study. | 2014 | Details |
| A22160 | 24781986 | PLoS One | Chemokine-like receptor 1 deficiency does not affect the development of insulin resistance and nonalcoholic fatty liver disease in mice. | 2014 | Details |
| A22161 | 30736156 | Expert Rev Endocrinol Metab | Insulin-like growth factors (IGF-I and -II): new actors in the development of non-alcoholic fatty liver disease. | 2014 | Details |
| A22162 | 24777953 | Hepatology | Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis. | 2014 | Details |
| A22163 | 24777593 | Abdom Imaging | Assessment of liver volume with computed tomography and comparison of findings with ultrasonography. | 2014 | Details |
| A22164 | 24775330 | BMC Gastroenterol | Clinical predictors of incident gallstone disease in a Chinese population in Taipei, Taiwan. | 2014 | Details |
| A22165 | 24775093 | J Nutr Biochem | Diets enriched in trans-11 vaccenic acid alleviate ectopic lipid accumulation in a rat model of NAFLD and metabolic syndrome. | 2014 | Details |
| A22166 | 24772746 | J Assoc Physicians India | Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT). | 2013 | Details |
| A22168 | 24772164 | PPAR Res | Modes-of-Action Related to Repeated Dose Toxicity: Tissue-Specific Biological Roles of PPAR γ Ligand-Dependent Dysregulation in Nonalcoholic Fatty Liver Disease. | 2014 | Details |